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Background: To evaluate the use of optical coherence tomography (OCT) retinal nerve fiber layer (RNFL) thickness
and visual field (VF) measurements in detecting disease progression in patients with early glaucoma.
Methods: Over a 3-year period, this study examined 60 eyes of 39 glaucoma patients whose total deviation in the
superior or inferior hemifield was more than −6 dB. All eyes underwent at least four serial RNFL measurements
performed by Cirrus OCT, with the first and last measurements separated by at least three years. On the same day
as the RNFL imaging, VF testing was also performed by using the Swedish Interactive Threshold Algorithm Standard
30–2 program of the Humphrey Field Analyzer. Serial RNFL thicknesses and VF progression were assessed using
the Guided Progression Analysis (GPA) software program. RNFL thickness progression and VF progression were
evaluated by the event analysis.
Results: The mean observation period was 57.6 ± 10.0 months, and during this time, a total of 366 OCT and 366 VF
measurements were performed. Using only OCT, progression was found in 2 eyes, while progression was found in
1 eye when only using VF GPA. When combined measurement findings were used, the analysis found progression
in 8 eyes.
Conclusions: When mild VF defect is present, OCT RNFL thickness measurements can be helpful in discerning
glaucoma progression.
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Glaucoma is a progressive optic neuropathy character-
ized by the loss of retinal ganglion cells and the retinal
nerve fiber layer (RNFL), with an associated visual field
loss [1,2]. In glaucoma, the precise nature of the relation-
ship between the structure and function is important, as it
can be used for detecting glaucomatous damage, deter-
mining the stage of the disease, and monitoring the pro-
gression of the disease.
In routine clinics, spectral-domain optical coherence
tomography (SD-OCT) has rapidly become one of the
most widely used technologies due to its high image
resolution and measurement precision. Changes in the
appearance of the RNFL thickness often precede the
development of glaucomatous visual field (VF) loss [3].
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unless otherwise stated.and progression of glaucomatous damage, a number of
studies have used SD-OCT to specifically focus on the
relationship between the structural and functional dam-
age. Results of these studies have demonstrated there are
high correlations between the global VF sensitivity and
the peripapillary RNFL [4,5]. In contrast, however, sev-
eral other studies have reported finding poor agreement
between the structure- and function-based results and
the extent of the progression [6-8]. We have recently re-
ported that the average of the progressive hemifield total
deviation (TD) at baseline for the both RNFL and VF
progression was −3.21 ± 1.38 dB, while individually it
was −2.17 ± 1.14 dB for RNFL progression and −9.12 ±
3.75 dB for VF progression [9]. In this study, if progres-
sion was noted in the inferior RNFL thickness, we then
evaluated the TD of the superior hemifield. The average
of the progressive hemifield TD demonstrated that there
was a significant advancement of VF progression as
compared to RNFL progression. Based on these results,l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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by OCT might be an important diagnostic tool, as these
measurements should be able to help discern glaucoma
progression when the VF defect is mild.
Therefore, the purpose of our current study was to
examine the relationship between the RNFL thickness
and VF measurements, and then evaluate the ability of




We performed a retrospective review of patients with
glaucoma who underwent OCT measurements of RNFL
thickness and VF testing at Kagawa University Hospital,
Kagawa, Japan, between October 2008 and January 2014.
Each of the eyes underwent at least four serial RNFL
measurements, with the first and last measurements sep-
arated by at least 3 years. All eligible subjects received a
detailed explanation of the study and signed an informed
consent form in accordance with the principles em-
bodied in the Declaration of Helsinki. This study was ap-
proved by the Institutional Review Board at Kagawa
University Hospital. At the baseline examination, all sub-
jects underwent a complete ophthalmic evaluation that
included visual acuity testing with refraction, intraocular
pressure, and dilated fundus examination with stereo-
scopic biomicroscopy of the optic nerve head using slit-
lamp and indirect ophthalmoscopy. To be included in
the study, all subjects had to have a best-corrected visual
acuity of 20/40 or better, a spherical error within a range
between +4.0 and −6.0 diopters, and a cylinder within ±
2.0 diopters. Exclusion criteria included a history of any
kind of retinal pathology, retinal laser procedure, retinal
surgery, or neurologic disease. In addition, we also ex-
cluded patients with advanced hemifield VF defect who
had an initial TD in the superior or inferior hemifield
under −6 dB. However, if the superior and the inferior
hemifield were each above −6 dB, we included both
hemifields. In addition, since we assessed each hemifield
in these patients, the global TD was not included in the
exclusion criteria. Glaucomatous eyes were defined as
eyes exhibiting structural glaucomatous changes (vertical
cup-disc asymmetry between fellow eyes of ≥ 0.2, a cup-
disc ratio of ≥ 0.6, and a neuroretinal rim narrowing,
notches, localized pallor, or RNFL defects with glau-
comatous VF loss in the corresponding hemifield). A
glaucomatous VF was defined as a glaucoma hemifield
test outside of the normal limits on at least two con-
secutive baseline tests and the presence of at least three
contiguous test points within the same hemifield on
the pattern deviation plot at P < 1%, with at least one
at P < 0.5% (excluding those points on the edge of the
field or those directly above and below the blind spot).VF testing and RNFL imaging were performed during
the same visit.
Cirrus HD-OCT RNFL measurement
Cirrus HD-OCT uses spectral domain technology (Carl
Zeiss Meditec, Dublin, CA). This technique utilizes an
optic disc cube that is generated from a 3-dimensional
data set composed of 200 A-scans from each of 200 B-
scans that cover a 6 mm2 area centered on the optic
disc. After creating an RNFL thickness map from the
cube, the software automatically determines the center
of the disc and then extracts a circumpapillary circle
(1.73 mm radius) from the data set. All of the images
obtained in the current study had signal strengths of at
least 6. The RNFL thickness deviation and the RNFL
thickness change maps were automatically generated by
the OCT instrument and exported to a computer that
analyzed the progression pattern of the RNFL defects.
The RNFL defects were visualized in the RNFL thickness
deviation map, which was composed of 50 × 50 pixels. A
pixel was coded in yellow if the RNFL measurement was
below the lower 95% and coded in red if below 99% of
the percentile ranges for that particular pixel.
The RNFL thickness change map was a component of
the Guided Progression Analysis (GPA) software (Carl
Zeiss Meditec), which provided both event- and trend-
based analysis of the RNFL progression based on the
serial RNFL thickness maps. This software automatically
aligned and registered the baseline and follow-up OCT
images so that the same pixel locations could be mea-
sured for change. In order to be able to generate a GPA
report, at least four patient visits were necessary. The
GPA program then overlaid and compared the serial
RNFL thickness against the duration of the follow-up.
Visual field examination
Standard visual field testing was performed using static
automated white-on-white threshold perimetry (Hum-
phrey Field Analyzer II (HFA); Carl Zeiss Meditec,
Dublin, CA), using the 30–2 Swedish Interactive Thresh-
old Algorithm Standard test. The visual field was defined
as reliable only when the fixation losses and the false-
positive and false-negative rates were less than 20%.
Only reliable test data were used in all of our analyses.
The GPA software compared the patient’s baseline vis-
ual field to each of the subsequent visual fields deter-
mined during the follow-up examinations. All baseline
values were obtained by averaging the data from the first
two exams. The progression evaluation was performed
relative to the baseline. The evaluation of the progres-
sion was carried out by comparing the threshold modifi-
cations to a database of stable glaucoma patients who
were tested over a very short period of time. These eval-
uations took into account the fluctuations related to






Age (y) 64.9 ± 10.9
Visual field measurements
Visual field tests 356
Average visual field tests per eye 5.4 ± 0.9
Baseline TD (dB) −2.75 ± 1.40
TD at final visit (dB) −4.05 ± 2.89*
OCT-RNFL measurements
OCT tests 356
Average OCT tests per eye 5.4 ± 0.9
Baseline average RNFL thickness (μm) 90.6 ± 20.6
Average RNFL thickness at final visit (μm) 87.7 ± 20.8**
*P < 0.001 compared with baseline.
**P < 0.05 compared with baseline.
TD, total deviation; dB; decibels, OCT, optical coherence tomography RNFL,
retinal nerve fiber layer.
Figure 1 A Venn diagram comparing the number of eyes with
progression as determined by OCT GPA and by HFA GPA.
The numbers within the diagram indicate the number of subjects
found with progression of the disease.
Hirooka et al. BMC Ophthalmology 2014, 14:118 Page 3 of 5
http://www.biomedcentral.com/1471-2415/14/118eccentricity and advancing disease. Each of the consecu-
tive tests examined the same locations (≥3) and deter-
mined if there was progression during any of the
consecutive VF tests. Based on the findings of a previous
study [10], “possible progression” was considered to be
present when the GPA printouts reported finding pro-
gression in 2 locations, while “likely progression” was
considered to be present when progression was found in
3 locations.
Analysis
Using the GPA software, RNFL thickness progression
was assessed by event analysis. Event analysis defined
progression as a change that exceeded a predefined limit
when compared to the baseline value. The baseline
values were obtained by averaging the data from the first
two exams. After completing a series of RNFL thickness
measurements, the GPA software then compared the
baseline RNFL thickness value to the final measurement
value. A “possible loss” was identified when the differ-
ences between the baseline and final measurement
values exceeded the test-retest variability. If the “possible
loss” criterion was met on two successive visits, the
patient was considered to show a “likely loss”. In the
current study, if the RNFL Thickness Map Progression
indicated that there was a “likely loss” or “possible loss”,
we defined the RNFL thickness as having progressed.
The VF GPA classification indicated “likely progression”
or “possible progression”, this was defined as progression
of the glaucoma.
Statistics
All statistical values are presented as mean ± standard
deviation (SD), with P values < 0.05 considered statisti-
cally significant. Data were analyzed using a paired t-test.
Statistical analyses were performed using SPSS version
19.0 (IBM, New York).
Results
We analyzed 366 OCT scans and 366 VF test results ob-
tained from 60 eyes of 39 patients with glaucoma
(Table 1). The average number of OCT scans and VF
tests for each eye was 5.4. The follow-up duration
ranged from 36 to 70 months. Table 1 presents the pa-
tient’s demographics, along with the VF and RNFL mea-
surements. Mean age was 64.9 ± 10.9 years. The baseline
visual field TD and RNFL thickness values were −2.75 ±
1.40 dB (range, −0.79 to −6.00 dB) and 90.6 ± 20.6 μm
(range, 45 to 140 μm), respectively. Significant differ-
ences were observed between the baseline and the final
TD and RNFL thickness measurements (P < 0.05).
Eight eyes had concurrent progression in structure
and function. Topographical correspondence between
the VF progression and the RNFL progression waspresent in 8 eyes (Figure 1). In 3 of the 8 eyes, OCT
identified damage before it was detected by HFA. In 4
of the 8 eyes, both OCT and HFA detected progression
at the same time. In 1 out of 8 eyes, HFA identified pro-
gression before it was detected by OCT. OCT GPA re-
ported that 2 eyes exhibited progression, while VF GPA
showed there was progression in 1 eye (Figure 1).
Table 2 shows the RNFL measurements in eyes with
or without progression. Significant differences were ob-
served between the baseline and the final measurements
(P < 0.001). Figure 2 shows the initial and final RNFL
thickness in each eye with progression.






(8 eyes) (52 eyes)
Baseline average RNFL
thickness (μm)
83.6 ± 19.7 91.9 ± 20.6
Average RNFL thickness
at final visit (μm)
72.9 ± 25.4* 90.6 ± 18.6
*P < 0.05 compared with baseline.
RNFL, retinal nerve fiber layer.
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provement. However, OCT in this eye showed the oppos-
ite, indicating that there was no significant improvement.
Discussion
Worsening optic disc excavation, RNFL atrophy and de-
terioration in visual function are all used to detect the
progression of glaucoma. If progression is confirmed,
treatment needs to be modified or enhanced in order to
prevent further irreversible loss of the patient’s visual
function. In the current study, we evaluated the effect-
iveness of using OCT RNFL thickness and VF measure-
ments by HFA to detect progression in patients with
early glaucoma.
It has been previously recommended that glaucoma be
monitored by both VF and digital imaging devices [11].
However, it has been reported that there is poor agree-
ment between the VF and RNFL results when used to
detect progression [6-8]. Structural assessment by OCT
has been shown to be much worse when performed dur-
ing advanced stages of damage [12]. It has been further
reported that a complete loss in standard automated
perimetry sensitivity is not due to an RNFL thickness of
zero, but is in fact is associated with a finite RNFL thick-
ness. Previous findings have also shown that there is a
minimum value beyond which the thickness cannot be


















Figure 2 RNFL thickness changes in the 8 patients who fit
progression criteria by OCT and HFA.to the number of axons [12]. For these reasons, our
study excluded the initial TD in the superior or inferior
hemifield when values were under −6 dB as changes in
RNFL thickness with this advanced loss are minimal.
In 7 of the 8 eyes in which both techniques reported
progression, OCT was able to identify damage prior
to or at the same time that HFA detected the damage.
Results of previous cross-sectional studies in early glau-
coma patients have also suggested that progression
determined by the RNFL thickness is more noticeable
than that determined by the visual field, based on the
observed curvilinear structure-function relationship
[13-15]. Furthermore, it is notable that depending on
the stage of the disease, the ability to detect progression
may vary considerably between the structural and func-
tional tests. HFA seems to be relatively insensitive when
detecting changes in early glaucoma, whereas OCT
seems to perform relatively worse during the advanced
stage of glaucoma.
In our current study, an event-based approach was se-
lected for analysis of both the structural and functional
progression. When using trend analysis, one important
assumption is that the amount of change will be linearly
proportional to the duration of the follow-up. However,
it is known that the rate of progression can vary over
time due to loosening or tightening of the control of the
glaucoma treatment, as well as due to changes related to
the natural progression of the disease. For this reason,
our study assessed the functional and structural progres-
sions by using the event analysis of the GPA software for
both the HFA and OCT.
The limitations of our present work include having a
small sample size and a small number of tests. There-
fore, larger studies will need to be undertaken in the fu-
ture in order to be able to more precisely determine the
structure-function relationship present when detecting
the glaucoma progression.
Conclusions
In conclusion, our current study demonstrated in this
limited group that there was good agreement between
the structural and functional tests used to evaluate glau-
coma progression during the early stage of the disease.
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